Blue Note Therapeutics
San Francisco, US · Founded 2018 · Delaware corporation
Healthtech
Founders & leadership
AF
Andrew FirlikNamed on SEC filing
GE
Geoffrey EichNamed on SEC filing
JH
John HarrisNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$15.5M disclosed across 1 round · 2021
▶$15.5MraisedAug 2021 · 4 investors · Other Health CareRule 506(b)
▶$15.5MraisedAug 2021 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew FirlikDirector
- Geoffrey EichExecutive Officer, Director
- John HarrisDirector
- Offering amount
- $50M
- Amount sold
- $15.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Blue Note Therapeutics raised?
- Blue Note Therapeutics has disclosed $15.5M raised across 1 round.
- Where is Blue Note Therapeutics headquartered?
- Blue Note Therapeutics is headquartered in San Francisco, US.